…: it will be imho because that patient probably was diagnosed 5 years ago, plateaued 4 years ago, and MPL had nothing to do with bio marker stability. & mgmt know if that’s published we would all reach my conclusion.
Again I’m not saying that patient is not benefiting from MPL. Just this data, you cannot draw conclusions.
Ann: Additional Phase 1 data suggest MPL may inhibit MND, page-154
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.025(13.5%) |
Mkt cap ! $83.14M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 22.0¢ | 20.0¢ | $733.4K | 3.538M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 113800 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 240088 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
0.025 ( 13.5 %) |
||||
| Open | High | Low | Volume | ||
| 20.5¢ | 22.0¢ | 20.0¢ | 1388603 | ||
| Last updated 15.56pm 31/05/2024 ? | |||||
| PAA (ASX) Chart |